GlaxoSmithKline PLC — Director's Dealing 2017

Apr 25, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3201D

GlaxoSmithKline PLC

25 April 2017

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr B McNamara

b)

Position/status

CEO, Consumer Healthcare

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

b)

Nature of the transaction

Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 13 April 2017 on shares held in the Deferred Annual Bonus Plan Post-Tax - matching award.

c)

Price(s) and

volume(s)

Price(s)	Volume(s)
$41.1461	28.716

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

e)

Date of the transaction

2017-04-25

f)

Place of the transaction

New York Stock Exchange (XNYS)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHQELFLDZFFBBQ